Paper - WANFANG MED ONLINE

You Position: Home > Paper

Challenge and thought on treatment of diffuse gastric cancer

( views:7, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 17

DOI:: 10.11569/wcjd.v24.i17.2608

Key Word:: 弥漫型胃癌;Lauren分型;治疗;Diffuse gastric cancer;Lauren type;Treatment

Abstract：弥漫型胃癌是胃癌Lauren病理分型的一种,其恶性程度高,易发生转移,在我国发病率呈逐年上升趋势,成为严重威胁人类健康的重要疾病类型.目前,该病治疗仍然非常困难,很难获得满意疗效,因此近年来国内外对弥漫型胃癌研究较多,其治疗效果及预后等均有所改善.本文在阅读大量相关中外文献基础上从流行病学、诊断治疗、生物学行为的变化、影响疗效及预后的因素等多个方面对弥漫型胃癌进行系统阐述,在此基础上对目前该病诊断治疗过程中存在的问题及争议进行讨论,以方便对其开展进一步研究,并对相关临床工作提供帮助.

Reference

[1]Hye Won Chung,Sung Hoon Noh,Jong-Baeck Lim.Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea[J].2010,(2).
[2]李文会,辛彦.KiSS-1和MMP-9在胃癌及其癌前病变中的表达和临床病理意义[J].2014,(11).
[3]陈凛,张勇,卫勃,等.2335例胃癌外科治疗的临床分析[J].2007,(5).
[4]徐胜军,胡炳奎,凌志强,等.CD44v6在胃癌中的表达及其临床意义[J].2006,(1).
[5]魏志刚,卿三华.腹腔热灌注化疗治疗胃肠癌[J].2006,(2).
[6]Liu HF,Liu WW,Fang DC,etc.Expression and significance of proapoptotic gene Bax in gastric carcinoma[J].1999,(1).
[7]贺宏勇,汪学非,沈振斌,等.转录抑制因子Snail表达与胃癌Lauren分型的关系研究[J].2012,(8).
[8]隋洺骅,张良明.Lauren分型肠型和弥漫型胃癌的临床特点及预后的分析[J].2013,(22).
[9]白鸽,初建虎,郑超,等.胃癌 Lauren 分型临床特点及预后分析[J].2015,(10).
[10]易伟,胡志前,龚振斌.Ki-67抗原和p53蛋白在胃癌中的表达及其临床意义[J].2006,(9).
[11]苏林,辛彦.E-cadherin和FSP-1/S100A4在胃癌及其癌前病变中的表达与临床病理意义[J].2014,(12).
[12]国家"863"重大项目"胃癌分子分型与个体化诊疗"课题组.胃癌病理分型和诊断标准的建议[J].2010,(4).
[13]何裕隆.胃癌病理分型研究进展[J].2005,(7).
[14]薛鹏,周翡,李宁,等.胃癌中PTEN和p-AKT蛋白的表达及其临床意义与预后分析[J].2012,(4).
[15]储婧,秦蓉,王娜娜,等.胃癌及癌旁组织中CDX2和claudin-3的表达及其意义[J].2011,(12).
[16]J B, Koea,M S, Karpeh,M F, Brennan.Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients.[J].2000,7(5).
[17]PEKKA LAURÉN.The Two Histological Main Types of Gastric Carcinoma: Diffuse and so-Called Intestinal-Type Carcinoma[J].1965,64(1).
[18]Myung Jin, Nam,Seung Jong, Oh,Cheong Ah, Oh,etc.Frequency and predictive factors of lymph node metastasis in mucosal cancer.[J].2010,10(4).
[19]赵俞玲.647例胃癌Lauren分型临床与病理特点研究[D].2014.
[20]Choi JH,Sheen SS,Han JH,etc.Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy.[J].2011,56(1).
[21]Hehr T,Hass HG,Jager C,etc.Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren's): single-center experience of 160 cases.[J].2011,34(12).
[22]Gunderson LL,Smalley SR,Hundahl SA,etc.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.[J].2001,345(10).
[23]Kim, In-Ho,Chae, Hyun-Dong,Jeon, Chang-Ho.Prognostic Value of Genetic Detection Using CEA and MAGE in Peritoneal Washes With Gastric Carcinoma After Curative Resection Result of a 3-Year Follow-Up[J].2014,93(11).
[24]Irena Oblak,Franc Anderluh,Vaneja Velenik.Postoperative radiochemotherapy for gastric adenocarcinoma: long term results[J].2009,(4).
[25]Ruey-Long Hong,Wei-Jei Lee,Chia-Tung Shun,etc.Expression of CD44 and Its Clinical Implication in Diffuse-Type and Intestinal-Type Gastric Adenocarcinomas[J].1995,52(4).
[26]江慧,宋纯,张桂荣,等.HER2阳性胃癌临床病理特征分析[J].2014,(5).
[27]J, Yu,M P, Ebert,S, Miehlke,etc.Alpha-Catenin Expression is Decreased in Human Gastric Cancers and in the Gastric Mucosa of First Degree Relatives.[J].2000,46(5).
[28]Miaozhen, Qiu,Yixin, Zhou,Xinke, Zhang,etc.Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.[J].2014,14.
[29]Hartgrink HH,van de Velde CJ.Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer.[J].2005,90(3).
[30]Pattison, Sharon,Mann, G. Bruce,Crosthwaite, Gary,etc.Predictors of outcome after surgery for gastric cancer in a Western cohort[J].2016,86(6).
[31]Maekita,T.,Yamashita,S.,Deguchi,H.,etc.Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis[J].2013,16(4).
[32]Nardone G.Molecular basis of gastric carcinogenesis.[J].2003,17(Suppl 2).
[33]Li C,Oh SJ,Kim S,etc.Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.[J].2009,77(3/4).
[34]徐志远,程向东,杜义安,等.ZIP4蛋白在胃癌中的表达及其临床意义[J].2013,(6).
[35]J S, Spratt,R A, Adcock,M, Muskovin,etc.Clinical delivery system for intraperitoneal hyperthermic chemotherapy.[J].1980,40.
[36]Bang YJ,Van Cutsem E,Feyereislova A,etc.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.[J].2010,376(9742).
[37]Sarbia M,Becker KF,Hofler H.Pathology of upper gastrointestinal malignancies.[J].2004,31(4).
[38]P H, Sugarbaker,W J, Cunliffe,J, Belliveau,etc.Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer.[J].1989,16.
[39]Mai M,Hara T,Kobayashi M,etc.Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.[J].1998,78(9).
[40]Hatakeyama M.Helicobacter pylori and gastric carcinogenesis.[J].2009,44(4).
[41]刘伟,余英豪,欧阳学农,等.P53和Ki67在胃癌中的表达及其临床意义[J].2011,(4).
[42]S A, Gayther,K L, Gorringe,S J, Ramus,etc.Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.[J].1998,58.
[43]Bai, Y. Q.,Yamamoto, H.,Akiyama, Y.,etc.Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach[J].2002,176(1).
[44]燕速,李斌,马旭祥,等.河湟谷地青年型胃癌临床病理特征分析[J].2015,(5).
[45]An JY,Noh SH,Lee YC,etc.High microsatellite instability predicts good prognosis in intestinal-type gastric cancers.[J].2011,26(3).
[46]Milne AN,Carneiro F,O'Morain C.Nature meets nurture: molecular genetics of gastric cancer.[J].2009,126(5).
[47]Sipponen P,Vauhkonen M,Vauhkonen H.Pathology and molecular biology of gastric cancer.[J].2006,20(4).
[48]Ema,A.,Yamashita,K.,Sakuramoto,S.,etc.Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy[J].2014,17(1).
[49]H, Takiuchi,I, Hirata,S, Kawabe,etc.Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma.[J].1900,7.